By submitting, you consent that you are at least 18 years of age and to receive information about MPR's or APMG entities' programs and offerings. The personally identifying information you provide will not be sold, shared, or used for purposes other than to communicate with you about MPR, APMG entities, and its sponsors. You may opt-out at any time clicking the unsubscribe link at the bottom of any email communication. View our Privacy Policy.
As of Nov. 13, roughly 720,000 doses of the recently available updated COVID-19 vaccine have been administered in Minnesota, accounting for just over 13 percent of the population. COVID-19, flu and RSV hospitalizations remain well below this time last year.
Scientists studying the causes of long COVID symptoms are proposing a surprising pathway. Their research weaves together several prominent lines of evidence on what might be driving the condition.
There are widespread delays in the COVID-19 vaccine supply chain from both Pfizer and Moderna. That’s made it hard for health systems to schedule appointments, especially for young children.
Emergency room visits for COVID-19 have dropped during the last couple of weeks in Minnesota. While there is no guarantee that trend will continue, there has been a longer downward trend for the United States as a whole.
Two scientists have won the Nobel Prize in medicine for discoveries that enabled the development of mRNA vaccines against COVID-19 and could be used in the future to create other shots.
We’re entering a challenging time of year, when COVID-19, flu and RSV collide. Get the latest information on preventive measures for each, as well as data on how much COVID is circulating in Minnesota.
A Duluth developer announced plans this week to convert a 50-year old downtown office building into apartments. It’s the first of what the city hopes will be several office-to-housing conversions in the next several years as Duluth works to revitalize its downtown post-pandemic.
The Biden administration announced Wednesday that it is providing $600 million in funding to produce new at-home COVID-19 tests and is restarting a website allowing Americans to again order up to four free tests per household.